title: ViiV Healthcare showcases breadth of clinical and real-world evidence at EACS and IDWeek 2025
source: Yahoo
date: 2025-10-09
url: https://finnhub.io/api/news?id=055acc4d59cc2ad7a2fdd2df76b8afd5bee0520cd7343a2b638c9e98b98c45d5
LONDON, October 09, 2025--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of more than 60 abstracts, including data from its industry-leading long-acting HIV treatment and prevention portfolio, at the 20th European AIDS Conference (EACS) in Paris, France from 15-18 October, and at IDWeek 2025 in Atlanta, Georgia, US from 19-22 October.
